These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 36070065
1. PHIL® (precipitating hydrophobic injectable liquid): retrospective multicenter experience on 178 patients in peripheral embolizations. Giurazza F, Cionfoli N, Paladini A, Vallone M, Corvino F, Teodoli L, Moramarco L, Quaretti P, Catalano C, Niola R, Lucatelli P. Radiol Med; 2022 Nov; 127(11):1303-1312. PubMed ID: 36070065 [Abstract] [Full Text] [Related]
2. Embolization of peripheral arteriovenous malformations and fistulas with precipitating hydrophobic injectable liquid (PHIL®). Giurazza F, Corvino F, Silvestre M, Cangiano G, De Magistris G, Cavaglià E, Amodio F, Niola R. Radiol Med; 2021 Mar; 126(3):474-483. PubMed ID: 32889705 [Abstract] [Full Text] [Related]
3. Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model. Vollherbst DF, Otto R, von Deimling A, Pfaff J, Ulfert C, Kauczor HU, Bendszus M, Sommer CM, Möhlenbruch MA. J Neurointerv Surg; 2018 Mar; 10(3):268-274. PubMed ID: 28689184 [Abstract] [Full Text] [Related]
4. Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model. Vollherbst DF, Sommer CM, Ulfert C, Pfaff J, Bendszus M, Möhlenbruch MA. AJNR Am J Neuroradiol; 2017 Jul; 38(7):1377-1382. PubMed ID: 28522669 [Abstract] [Full Text] [Related]
5. Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study. Lamin S, Chew HS, Chavda S, Thomas A, Piano M, Quilici L, Pero G, Holtmannspolter M, Cronqvist ME, Casasco A, Guimaraens L, Paul L, Gil Garcia A, Aleu A, Chapot R. AJNR Am J Neuroradiol; 2017 Jan; 38(1):127-131. PubMed ID: 27932510 [Abstract] [Full Text] [Related]
6. Intermixed Dimethyl-Sulfoxide-Based Nonadhesive Liquid Embolic Agents Delivered Serially via the Same Microcatheter for Cerebral AVM Treatment. Sirakov A, Minkin K, Sirakov S. AJNR Am J Neuroradiol; 2020 Apr; 41(4):681-686. PubMed ID: 32165357 [Abstract] [Full Text] [Related]
7. Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations. Sirakov SS, Sirakov A, Minkin K, Hristov H, Ninov K, Penkov M, Karakostov V, Orlov K, Gorbatykh A, Kislitsin D, Raychev R. Interv Neuroradiol; 2019 Feb; 25(1):58-65. PubMed ID: 30223686 [Abstract] [Full Text] [Related]
8. Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations. Koçer N, Hanımoğlu H, Batur Ş, Kandemirli SG, Kızılkılıç O, Sanus Z, Öz B, Işlak C, Kaynar MY. Diagn Interv Radiol; 2016 Feb; 22(2):184-9. PubMed ID: 26782157 [Abstract] [Full Text] [Related]
9. Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note. Leyon JJ, Chavda S, Thomas A, Lamin S. J Neurointerv Surg; 2016 Jun; 8(6):596-602. PubMed ID: 25994938 [Abstract] [Full Text] [Related]
11. Treatment of Type II Endoleaks with a Novel Agent: Precipitating Hydrophobic Injectable Liquid (PHIL). Helmy A, Shaida N. Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1094-1098. PubMed ID: 28194506 [Abstract] [Full Text] [Related]